Abstract
#Dyslipidemia is highly common in women, particularly after the
menopause. #Menopause, caused by ovarian dysfunctions, is be associated
with an increase in total and low-density lipoprotein-cholesterol
(LDL-C) and a decrease in high density #lipoprotein-cholesterol (HDL-C).
#Pitavastatin (2 mg/day, orally), one of new generation statin, in
addition to its strong LDL-C lowering effect, revealed a higher efficacy
to
increase HDL-C level and improved elevated triglyceride (TG) level in
Japanese peri- and postmenopausal women. Pitavastatin may be an
effective #treatment option in (post-)menopausal women with dyslipidemia,
in conjunction with suggested lifestyle modification.
For more Biomedical Open Access Journals please click on https://biomedres.us/
For more Research Articles on BJSTR
Efficacy and Safety of Pitavastatin in #Menopausal Women with #Dyslipidemia by Atsushi Imai in BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.